• Mitochondrial IRF3 Impairs Mitophagy and Drives Pulmonary Fi

  2026-05-05

  This study uncovers a novel pathogenic mechanism in pulmonary fibrosis, demonstrating that mitochondrial translocation of IRF3 impairs mitophagy and triggers ferroptosis in alveolar epithelial cells. These findings reveal the IRF3-mitophagy-ferroptosis axis as a promising therapeutic target and refine experimental approaches for modeling fibrosis and epithelial injury.

• Firefly Luciferase mRNA (ARCA, 5-moUTP): Precision Tools for

  2026-05-04

  Firefly Luciferase mRNA (ARCA, 5-moUTP) from APExBIO sets a new standard for robust, immune-silent, and highly sensitive bioluminescent reporting in gene expression and viability assays. Its advanced modifications deliver superior stability and translational efficiency, unlocking reproducible, high-throughput workflows and enabling innovative delivery strategies.

• Octanoic Acid Nutrition Modulates IBD via PPARγ/STAT Pathway

  2026-05-04

  This study reveals that octanoic acid-rich enteral nutrition (OA-EN) alleviates inflammatory bowel disease by modulating intestinal macrophage polarization through the PPARγ/STAT-1/STAT-6 pathway. The findings provide mechanistic insight into nutritional immune modulation and suggest new strategies for IBD intervention.

• Tolazoline: Strategic Insights for Translational Researchers

  2026-05-03

  This thought-leadership article explores Tolazoline’s dual mechanism as an α2-adrenergic receptor antagonist and ATP-sensitive potassium channel blocker, providing translational researchers with mechanistic clarity, protocol guidance, and strategic perspective. Drawing on recent literature, quantitative data, and comparative analysis, we position APExBIO’s Tolazoline as a uniquely versatile tool for dissecting neuroendocrine and airway pathways. The article bridges mechanistic nuance with workflow optimization and forward-looking recommendations for researchers seeking reproducibility and translational relevance.

• Ciprofloxacin: Advanced Fluoroquinolone Antibiotic Workflows

  2026-05-02

  Ciprofloxacin is not only a gold-standard fluoroquinolone antibiotic for antibacterial research, but also enables innovative approaches in drug delivery and resistance modeling. Discover how recent nanomedicine breakthroughs and robust protocol design maximize its impact in both classic and next-generation laboratory settings.

• α2-Adrenergic Agonists for Immune Modulation in Osteosarcoma

  2026-05-01

  This study demonstrates that α2-adrenergic receptor agonists, delivered via a thermo-sensitive hydrogel, reduce immune rejection and tumor recurrence in post-surgical osteosarcoma models through T cell activation. Findings provide a mechanistic basis for targeting α2-AR signaling to enhance anti-tumor immunity and inform the design of advanced therapeutic strategies.

• Alcian Blue & Nuclear Fast Red Staining Kit: Scientific Foun

  2026-05-01

  Explore the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5 as a cornerstone tool for advanced histological staining of mucopolysaccharides and chondrogenic differentiation. This article provides a rigorous, evidence-grounded analysis of the assay’s mechanisms and protocol optimization strategies.

• High-Throughput BBB Model Enhances CNS Drug Screening Accura

  2026-04-30

  This study introduces a robust surrogate blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells combined with lysosomal trapping correction, providing high predictive accuracy for CNS drug permeability. Its findings lay the groundwork for more efficient early-stage screening of brain-penetrant compounds and address longstanding challenges in modeling BBB transport mechanisms.

• Carbon-Ion Radiotherapy Induces Ferroptosis in Gastric Cance

  2026-04-30

  Wang and Cai (2025) reveal that carbon-ion radiotherapy (CIRT) suppresses gastric cancer progression by inducing ferroptosis and promoting M1 macrophage polarization through downregulation of DHODH. This mechanistic insight highlights a potential strategy to enhance radiotherapy efficacy in treatment-resistant gastric tumors.

• Haloprogin: Broad-Spectrum Antifungal and Antibacterial Insi

  2026-04-29

  The landmark 1970 study systematically established Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as an effective topical antifungal agent with a uniquely broad spectrum, including potent activity against dermatophytes, Candida species, and selected Gram-positive bacteria. These findings inform contemporary protocols for infection model research and highlight Haloprogin’s distinct profile versus tolnaftate.

• Redefining α2-AR Agonists: Translational Leverage in Osteosa

  2026-04-29

  This article reframes the application of 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, a selective α2-adrenergic receptor agonist, for translational researchers targeting post-surgery osteosarcoma recurrence. Integrating mechanistic insight, rigorous experimental validation, and strategic guidance, we map out new opportunities for immune rejection modulation and advanced drug delivery. Drawing from the latest published study and related expert resources, this analysis not only benchmarks APExBIO’s offering in the research reagent landscape but also sets a forward-looking agenda for next-generation receptor signaling research.

• hiPSC-Derived Intestinal Organoids: Advances for PK Studies

  2026-04-28

  This study presents a streamlined protocol to generate human intestinal organoids from pluripotent stem cells, enabling robust in vitro pharmacokinetic analysis. By improving physiological relevance over traditional models, this work offers a scalable platform for drug absorption and metabolism studies.

• G418 Sulfate (Geneticin): Mechanism, Evidence, and Applicati

  2026-04-28

  G418 Sulfate (Geneticin) is a high-purity aminoglycoside antibiotic essential for genetic engineering selection and antiviral research. It acts via 80S ribosome inhibition, reliably selects neomycin-resistant cells, and demonstrates antiviral activity against Dengue virus serotype 2. Supported by peer-reviewed evidence and robust product specifications, it is a cornerstone for modern cell culture workflows.

• ONX-0914 (PR-957): Protocol Optimization in Autoimmune Model

  2026-04-27

  ONX-0914 (PR-957) empowers researchers to dissect immunoproteasome function with unmatched selectivity, accelerating breakthroughs in autoimmune disease and cytokine modulation. This guide distills experimental workflows, troubleshooting strategies, and novel insights from the latest airway epithelium research for real-world bench applications.

• Genistein in Cancer Chemoprevention: Protocols and Innovatio

  2026-04-27

  Genistein, a 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one, is redefining cancer biology research through selective tyrosine kinase inhibition and cytoskeleton-driven mechanotransduction. This guide delivers actionable protocols, troubleshooting strategies, and cutting-edge insights that bridge autophagy research with applied cancer chemoprevention.

15854 records 1/1057 page Next 12345 下5页 Last page